We can’t afford to lose germ-killing drugs

For once, the headlines about the latest health scare are not hyperbole: The end of the Antibiotics Era may be nigh. Staving it off will require fast and creative thinking not only in medical science, but also in public policy.

Public-health officials were horrified but not surprised to find a Pennsylvania woman who had an infection with the same kind of drug resistance first identified last fall on farms in China. The E. coli found in the woman carried the same genetic mechanism of resistance to colistin — a last-resort antibiotic — that was discovered in Chinese livestock that were routinely fed the drug. And this mechanism is easily spread from one bug to another.

The looming danger is that the gene for colistin resistance will make its way to bacteria already immune to carbapenem, another last-resort drug, creating an invincible “superbug.”

No one yet knows the magnitude of the agricultural threat because too many countries, including the U.S., fail to keep track of the amount and kinds of antibiotics fed to various livestock. This needs to change — and fast. In January, American farms are scheduled to stop feeding antibiotics to animals merely to help them grow. But this is a voluntary program, not a legal ban (as in Europe), and data will be needed to find out if the change makes a difference.

People are fed too many antibiotics, too. A study last month found that, in outpatient settings, about a third of prescriptions are written for conditions the drugs cannot treat. Add to that the frequency with which doctors prescribe broad-spectrum antibiotics because they don’t know which bug is causing a patient’s infection, and you’ve created a perfect environment for bacteria to develop resistance.

Ideally, medical science would maintain a full pipeline of new antibiotics to keep one step ahead of germ evolution. But that’s not the case — in part because antibiotics aren’t a particularly good business. Even more ideal would be to have novel formulations that are sparingly used, so as not to overexpose them to the bacterial resistance machinery.

What’s needed, from an economic standpoint, is a way to “de-link” the revenue from the sales of such drugs — that is, guarantee that drugmakers can get paid for effective new formulations. A British commission on antibiotic resistance has just recommended raising billions of dollars from world governments to make payments of this kind.

Improved medical technology is also necessary, including fast diagnostic tests that would help doctors treat infections more narrowly, as well as vaccines, probiotics and other nontraditional approaches. And if public money is to be spent in support of basic science aimed at discovering new kinds of germ-killing compounds, then drug companies should be prepared to share their proprietary compound libraries.

It’s some comfort to know that the Pennsylvania woman with the colistin-resistant infection has recovered; other drugs did the trick. So antibiotics aren’t quite useless yet. But public-health officials are right to warn that they soon will be — unless humans make a concerted effort to find new ways to fight the bacteria that threaten their existence.

The above editorial appeared on Bloomberg View, www.bloomberg.com/view.

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Opinion

toon
Editorial cartoons for Thursday, March 28

A sketchy look at the news of the day.… Continue reading

Initiative promoter Tim Eyman takes a selfie photo before the start of a session of Thurston County Superior Court, Wednesday, Feb. 10, 2021, in Olympia, Wash. Eyman, who ran initiative campaigns across Washington for decades, will no longer be allowed to have any financial control over political committees, under a ruling from Superior Court Judge James Dixon Wednesday that blasted Eyman for using donor's contributions to line his own pocket. Eyman was also told to pay more than $2.5 million in penalties. (AP Photo/Ted S. Warren)
Editorial: Initiative fee increase protects process, taxpayers

Bumped up to $156 from $5, the increase may discourage attempts to game the initiative process.

Protecting forests and prevent another landslide like Oso

Thank you for the powerful and heartbreaking article about the Oso landslide… Continue reading

Boeing’s downfall started when engineers demoted

Boeing used to be run by engineers who made money to build… Continue reading

Learn swimming safety to protect kids at beach, pool

Don’t forget to dive into water safety before hitting the pool or… Continue reading

Comment: Why shootings have decreased but gun deaths haven’t

High-capacity magazines and ‘Glock switches’ that allow automatic fire have increased lethality.

Washington state senators and representatives along with Governor Inslee and FTA Administrator Nuria Fernandez break ground at the Swift Orange Line on Tuesday, April 19, 2022 in Lynnwood, Washington. (Olivia Vanni / The Herald)
Editorial: Community Transit making most of Link’s arrival

The Lynnwood light rail station will allow the transit agency to improve routes and frequency of buses.

An image of Everett Mayor Cassie Franklin is reflected in a storefront window during the State of the City Address on Thursday, March 21, 2024, at thee Everett Mall in Everett, Washington. (Ryan Berry / The Herald)
Editorial: State of city address makes case for Everett’s future

Mayor Franklin outlines challenges and responses as the city approaches significant decisions.

FILE - The massive mudslide that killed 43 people in the community of Oso, Wash., is viewed from the air on March 24, 2014. (AP Photo/Ted S. Warren, File)
Editorial: Mapping landslide risks honors those lost in Oso

Efforts continue in the state to map areas prone to landslides and prevent losses of life and property.

toon
Editorial cartoons for Wednesday, March 27

A sketchy look at the news of the day.… Continue reading

Burke: ‘Why not write about Biden, for once?’ Don’t mind if I do.

They asked; I’ll oblige. Let’s consider what the president has accomplished since the 2020 election.

Comment: Catherine missed chance to dispel shame of cancer

She wasn’t obligated to do so, but she might have used her diagnosis to educate a sympathetic public.

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.